POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Did Not Advance

Oregon Expands Drug Manufacturer Annual Reporting to Include Patient Assistance Programs Starting in 2028

Original title: Expands drug manufacturer annual reporting requirements to include all patient assistance programs offered or funded by the manufacturer that provided assistance to consumers in this state in the previous calendar year.

Last action · March 6, 2026: In committee upon adjournment.

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

Oregon Senate Bill 1528 expands annual reporting requirements for prescription drug manufacturers to include all s offered or funded by the manufacturer that provided consumer assistance in the state during the previous calendar year, becoming operative on January 1, 2028.

Why it matters

Drug manufacturers selling prescription drugs in the state must disclose detailed consumer assistance data, including participant counts, total cost-reduction values, and eligibility criteria, subjecting non-compliant manufacturers to civil penalties.

Background
  • Oregon's existing prescription drug price transparency laws require manufacturers to report certain price increases and drug development costs to the Department of Consumer and Business Services. context
  • The Legislative Assembly utilizes annual reports compiled by the department to consider legislative measures aimed at containing prescription drug costs. context

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

Prescription drug manufacturers

Prescription drug manufacturers must compile and submit annual reports detailing patient assistance programs and pricing data to the Department of Consumer and Business Services and face potential civil penalties for non-compliance.

Directly affected

Consumers residing in this state

Consumers participate in patient assistance programs and have access to an online or telephone notification process to report prescription drug price increases to the department.

Directly affected

Department of Consumer and Business Services

The department is responsible for receiving reports, verifying data, posting information to its website, sharing data with the Prescription Drug Affordability Board, and reporting annually to the Legislative Assembly.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What new information must drug manufacturers report under Senate Bill 1528?
Manufacturers must report details about all s offered or funded by them that provided assistance to state consumers in the previous calendar year, including participant counts, total value of cost reductions, qualifying refill counts, program duration, and eligibility criteria.
What happens if a manufacturer fails to submit the required reports or provides inaccurate data?
Manufacturers may be subject to civil penalties under ORS 646A.692 for failing to submit timely reports, failing to provide required information, failing to respond to additional information requests, or providing inaccurate or incomplete information.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · passed the Senate · in House committee.

Procedural history

11 actions
  1. Mar 6, 2026House
    In committee upon adjournment.
  2. Mar 2, 2026House
    Public Hearing held.
  3. Feb 24, 2026House
    Referred to Rules.
  4. Feb 24, 2026House
    First reading. Referred to Speaker's desk.
  5. Feb 24, 2026Senate
    Third reading. Carried by Patterson. Passed.
  6. Feb 23, 2026Senate
    Second reading.
Show 5 earlier actions
  1. Feb 20, 2026Senate
    Recommendation: Do pass with amendments. (Printed A-Eng.)
  2. Feb 16, 2026Senate
    Work Session held.
  3. Feb 11, 2026Senate
    Public Hearing held.
  4. Feb 2, 2026Senate
    Referred to Health Care.
  5. Feb 2, 2026Senate
    Introduction and first reading. Referred to President's desk.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Expansion of Annual Drug Reporting

Senate Bill 1528 broadens existing manufacturer price reporting mandates to encompass direct patient assistance programs such as copay cards and coupons.

Connected Entities

Prescription Drug Affordability Board, Public Employees' Benefit Board, Oregon Health Authority and 7 more
OrganizationPrescription Drug Affordability Board“Board that receives lists of prescription drugs and pricing information from the”Map →
OrganizationPublic Employees' Benefit Board“State board included in the department's annual legislative report recommendatio”Map →
OrganizationOregon Health Authority“State authority included in the department's annual legislative report recommend”Map →
OrganizationUnited States Food and Drug Administration“Federal agency that grants marketing approval, breakthrough therapy designation,”Map →
OrganizationOregon Educators Benefit Board“State board included in the department's annual legislative report recommendatio”Map →
OrganizationCOMMITTEE ON HEALTH CARE“Senate committee that introduced the amendments to Senate Bill 1528”Map →
OrganizationDepartment of Corrections“State agency included in the department's annual legislative report recommendati”Map →
OrganizationDepartment of Human Services“State department included in the department's annual legislative report recommen”Map →
PersonAttorney General“State official who may review decisions by the department to withhold trade secr”Map →
OrganizationDepartment of Consumer and Business Services“State department responsible for receiving manufacturer reports, establishing ru”Map →

Sources

Open source document

olis.oregonlegislature.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 65)
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz35
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record